German textbook, but the real reasons are deeper than this and reflect Otto's background and character. Perhaps this is why we have had to wait so long for the English version. But another reason is because of his attention to detail and, I strongly suspect, his not wanting to publish anything that did not meet his strict criteria for completeness and excellence. The result was that he never finished the translation and we must congratulate Mary for taking on the task and completing it.
The book starts with a brief historical introduction that serves to put the situation regarding the cortex in the 1980s in perspective. It is indeed very brief, but perhaps that gives an idea of Otto's view of the comparative infancy of the subject at that time. A chapter on phylogenetic and ontogenetic aspects of the cortex follows, again admirably brief but eminently readable. However, it is clear that we are reading the situation as it was a few years ago, as can only be expected.
from which most of the book benefited, but they still serve to mark what is enduring in the topic, without venturing to give excessive details on the 'very' new and, possibly, ephemeral. A surprise to me is that 'neurone' has the second 'e'. That was how I used to spell it until Otto told me to change, as that form was wrong, not reflecting the Greek! No compromise was possible. But, as you see, this journal does not follow Otto's advice! The next two chapters enter into Otto's very special domain, that of neurophysiology, and one must not forget that he was responsible for actually doing so much of what is written in this book, either himself or through his students and collaborators. It is pointless to describe these writings here: they must be read. Then there follow two chapters on the sensory, motor and association cortices, which bring together the points that Otto considered to be significant in them, and this emerges as an encyclopaedia of knowlscience. All the way through, I fel rigid discipline, but he provides mu for thought.
This book is compulsory read all in neuroscience research, an coming into it. It is history, written who helped make that history. B much more than that: it points to we have to go next. I am sure th would be pleased with how cortica science has progressed since he le get on with it without him. As I loo book now, my strongest impressi the pungent tobacco smoke that inevitable part of any encounte Otto. Is it possible that the publishe used some new technique to imp their printing paper, or is my Cerebri playing me up?
Laurence J Dept of A Charing Cross and Westminster
School, London, UK It has been said that 'neurologists know a lot but can do very little, neurosurgeons know very little but do a lot, and neuropathologists know everything -but by then it's too late'. This pessimism is being undermined by the increasing evidence for immunopathogenic mechanisms in some neurological conditions, and successful treatments based on this knowledge. This two-author book covers these developments and the clinical features of most of the known autoimmune neurological disorders, including 'paraneoplastic' disorders which are secondary to cancer in other tissues, and their animal models. The contents illustrate the great specificity with which the immune system can recognize individual neuronal proteins once selftolerance is broken. The nature and strength of the evidence for autoimmunity in a particular disease varies widely for different diseases. Multiple sclerosis (MS) is associated with lymphocytic infiltrates, loss of oligodendrocytes, demyelination and gliosis in the CNS. Expression of major histocompatibility complex class II molecules (on macrophages and astrocytes) is increased and CD4 + T cells are found in acute MS lesions. B-cell activation is evidenced by the presence of oligoclonal bands in the cerebrospinal fluid. Furthermore, the similarity of MS to the animal model, experimental autoimmune encephalitis (EAE), which develops following immunization with myelin antigens (myelin basic protein or proteolipid protein), and the presence of T cells reactive to myelin basic protein in MS patients provides circumstantial evidence for an autoimmune pathogenesis. However, it is not known whether the antigen-specific T cells are the primary cause of the disease, or reflect secondary sensitization to antigens exposed during demyelination from some unidentified primary event.
Even the pathogenic role of an to specific proteins is not always cl example, the 'stiff-man syndrom chronic condition in which disinhib upper motor neurones leads to neous contraction of agonist and an muscles resulting in severe muscle and painful spasms. About 50% of have antibodies to glutamic acid boxylase (GAD) that are restri inhibitory GABA-containing neuron pancreatic ␤ cells); some others, those with an associated cancer, ha bodies to amphiphysin. It seems able to suppose that a disease ch ized clinically and electrophysiolog excessive muscle contraction co mediated by an immune response d against a component of inhibitory ne It is more difficult to imagine the r antibodies to amphiphysin (a com of the vesicular membrane in man ent synapses) might play in this dis either case, the question arises as an immune response directed again plasmic antigens of neurones t supposed to be protected 'blood-brain barrier' can lead to n
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